Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$714K Sell
4,916
-1,615
-25% -$223K 0.17% 88
2026
Q2
$839K Sell
6,531
-554
-8% -$64.8K 0.21% 73
2026
Q1
$852K Buy
7,085
+2,293
+48% +$265K 0.23% 75
2025
Q4
$504K Buy
+4,792
New +$450K 0.15% 97
2024
Q3
– Sell
-1,957
Closed -$244K – 134
2024
Q2
$244K Buy
1,957
+400
+26% +$51.5K 0.13% 112
2024
Q1
$205K Buy
+1,557
New +$192K 0.12% 116
2023
Q3
– Sell
-1,945
Closed -$224K – 107
2023
Q2
$224K Hold
1,945
– – 0.15% 101
2023
Q1
$207K Sell
1,945
-289
-13% -$31.2K 0.17% 104
2022
Q4
$248K Buy
2,234
+1
+0% +$102 0.15% 103
2022
Q3
$192K Buy
+2,233
New +$199K 0.13% 109
2021
Q2
– Sell
-1,003
Closed -$73K – 255
2021
Q1
$73K Hold
1,003
– – 0.04% 172
2020
Q4
$79K Buy
+1,003
New +$76.7K 0.06% 165

Other funds holding MRK

COWA LLC's MRK Position: Q3 2026 in Review

COWA LLC reduced its Merck (MRK) stake by 25% in Q3 2026, selling an estimated $223K and leaving 4,916 shares worth $714K. The position accounts for 0.17% of the portfolio, ranked #88.

COWA LLC first reported a position in MRK in Q4 2020 and has held it in 12 quarters since. The position peaked at $852K in Q1 2026. 2,096 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • COWA LLC held 4,916 shares of Merck worth $714K as of Q3 2026.
  • COWA LLC sold 1,615 Merck shares in Q3 2026, an estimated $223K.
  • Merck made up 0.17% of COWA LLC's portfolio in Q3 2026, its #88 holding.
  • COWA LLC first reported a position in Merck in Q4 2020 and has held it in 12 quarters since.
  • COWA LLC's Merck position peaked at $852K in Q1 2026.
  • 2,096 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on COWA LLC's 13F filing for Q3 2026, filed 30 Oct 2026.